CureVac Financial Overview
CureVac's market cap is currently $936.76M. The company's EPS TTM is $-0.08191939000000001; its P/E ratio is 5.79; CureVac is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
